NCNA
Price
$0.08
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
32.78M
THAR
Price
$1.80
Change
+$0.04 (+2.27%)
Updated
Jun 27 closing price
Capitalization
7.59M
Interact to see
Advertisement

NCNA vs THAR

Header iconNCNA vs THAR Comparison
Open Charts NCNA vs THARBanner chart's image
NuCana
Price$0.08
Change-$0.00 (-0.00%)
Volume$10.62M
Capitalization32.78M
Tharimmune
Price$1.80
Change+$0.04 (+2.27%)
Volume$41.41K
Capitalization7.59M
NCNA vs THAR Comparison Chart in %
Loading...
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NCNA vs. THAR commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NCNA is a Hold and THAR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (NCNA: $0.08 vs. THAR: $1.80)
Brand notoriety: NCNA and THAR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NCNA: 9% vs. THAR: 38%
Market capitalization -- NCNA: $32.78M vs. THAR: $7.59M
NCNA [@Biotechnology] is valued at $32.78M. THAR’s [@Biotechnology] market capitalization is $7.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NCNA’s FA Score shows that 0 FA rating(s) are green whileTHAR’s FA Score has 1 green FA rating(s).

  • NCNA’s FA Score: 0 green, 5 red.
  • THAR’s FA Score: 1 green, 4 red.
According to our system of comparison, THAR is a better buy in the long-term than NCNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NCNA’s TA Score shows that 4 TA indicator(s) are bullish while THAR’s TA Score has 5 bullish TA indicator(s).

  • NCNA’s TA Score: 4 bullish, 3 bearish.
  • THAR’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, THAR is a better buy in the short-term than NCNA.

Price Growth

NCNA (@Biotechnology) experienced а -17.40% price change this week, while THAR (@Biotechnology) price change was +34.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NCNA($32.8M) has a higher market cap than THAR($7.59M). THAR YTD gains are higher at: -11.207 vs. NCNA (-93.059). THAR has higher annual earnings (EBITDA): -12.47M vs. NCNA (-16.98M). NCNA has more cash in the bank: 3.95M vs. THAR (1.08M). NCNA has less debt than THAR: NCNA (173K) vs THAR (271K). NCNA (0) and THAR (0) have equivalent revenues.
NCNATHARNCNA / THAR
Capitalization32.8M7.59M432%
EBITDA-16.98M-12.47M136%
Gain YTD-93.059-11.207830%
P/E RatioN/A0.02-
Revenue00-
Total Cash3.95M1.08M367%
Total Debt173K271K64%
FUNDAMENTALS RATINGS
NCNA: Fundamental Ratings
NCNA
OUTLOOK RATING
1..100
91
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NCNATHAR
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 19 days ago
79%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
NCNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
THAR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DOYU6.540.13
+2.03%
DouYu International Holdings Limited
SAN8.240.16
+1.98%
Banco Santander SA
JXN89.500.85
+0.96%
Jackson Financial
NTWK2.940.02
+0.68%
NetSol Technologies
TRUP56.00-0.24
-0.43%
Trupanion

NCNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NCNA has been closely correlated with CDTX. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if NCNA jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NCNA
1D Price
Change %
NCNA100%
N/A
CDTX - NCNA
93%
Closely correlated
+0.24%
NBY - NCNA
92%
Closely correlated
+0.97%
WINT - NCNA
92%
Closely correlated
+21.49%
RNAC - NCNA
92%
Closely correlated
-6.81%
SNPX - NCNA
92%
Closely correlated
+23.37%
More

THAR and

Correlation & Price change

A.I.dvisor indicates that over the last year, THAR has been closely correlated with CDTX. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if THAR jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To THAR
1D Price
Change %
THAR100%
+2.41%
CDTX - THAR
82%
Closely correlated
+0.24%
NBY - THAR
81%
Closely correlated
+0.97%
RNAC - THAR
81%
Closely correlated
-6.81%
NCNA - THAR
81%
Closely correlated
N/A
WINT - THAR
80%
Closely correlated
+21.49%
More